Corrigendum: Assessing the Function of the ZFP90 Variant rs1170426 in SLE and the Association Between SLE Drug Target and Susceptibility Genes

Front Immunol. 2022 Feb 18:13:840847. doi: 10.3389/fimmu.2022.840847. eCollection 2022.

Tingting Zhu^{1

2}, Yuandi Huang¹, Danfeng Qian³, Yuming Sheng¹, Chaowen Zhang¹, Shirui Chen¹, Hui Zhang¹, Hui Wang¹, Xuejun Zhang¹, Junlin Liu⁴, Changhai Ding^{2

5

6}, Lu Liu^{1

7}

¹ Department of Dermatology, The First Affiliated Hospital, Anhui Medical University, Hefei, China.
² Department of Rheumatology and Immunology, Arthritis Research Institute, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
³ Department of Dermatology, Lu'an People's Hospital, Lu'an, China.
⁴ Department of Dermatology, The Second Affiliated Hospital, Hainan Medical University, Haikou, China.
⁵ Clinical Research Centre, Zhujiang Hospital, Southern Medical University, Zhujiang, China.
⁶ Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.
⁷ Department of Medical and Molecular Genetics, King's College London, London, United Kingdom.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2021.611515.].

Keywords: SLE drug target genes; ZFP90; eQTL; single nucleotide polymorphism; systemic lupus erythematosus.